Clinical Trial: Comparative Bioavailability Study Between Etoricoxib / Betamethasone Administered Individually or in Combination

U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07454369) titled 'Comparative Bioavailability Study Between Etoricoxib / Betamethasone Administered Individually or in Combination' on Feb. 25.

Brief Summary: This study seeks to evaluate the comparative bioavailability of etoricoxib/betamethasone tablets 90 mg/0.25 mg test drug, administered in fixed combination vs. etoricoxib tablets 90 mg (Arcoxia(R)) reference drug, and betamethasone solution 50 mg/100 mL (Celestone(R) Pediatric) reference drug, administered individually, in a single dose, to 42 healthy mexican research subjects of both genders, under fasting conditions.

Study Start Date: Oct. 24, 2022

Study Type: INTERVENTIONAL

Condition: He...